📊 Have you seen the latest results from the RECAP study on intensive home hemodialysis with Physidia’s S³ system? 🏥 Conducted across 13 centers in France, this two-year study involving 80 patients demonstrates the safety and efficacy of short daily hemodialysis at home. Key findings include excellent dialysis adequacy markers and stable clinical performance. 🌟 Learn more about how the S³ system is transforming home hemodialysis by providing high-quality care and enhancing patient autonomy. 🔗 Read the full study : https://lnkd.in/gWm-BzwF By : Hafedh Fessi, Philippe NICOUD, Tomas Serrato, Olivia Gilbert, Cécile Courivaud, Salima Daoud, Marion Morena, MICHEL THOMAS, Bernard Canaud and Jean-Paul Cristol #Innovation #PatientCentric #HomeDialysis #HealthcareExcellence #Physidia 💡🩺🏡
I'll keep this in mind
Value Lead & Patient Access ILD strategy at Boehringer Ingelheim
2moWell done on the study and good clinical results. I am interested in how many sessions failed and the reasons behind this. Furthermore how many S3 needed to be swapped out during the study. It would be good to also see these results in the real world as s3 failure is a big worry for patients and results in consequences of having to arrange in hoise dialysis at the last minute not to mention lost earnings. #patientcentric